Trademark: 86028683
Word
KRINGLE PHARMA
Status
Dead
Status Code
711
Status Date
Friday, June 5, 2020
Serial Number
86028683
Registration Number
4545413
Registration Date
Tuesday, June 3, 2014
Mark Type
4000
Filing Date
Monday, August 5, 2013
Cancellation Date
Friday, June 5, 2020

Trademark Owner History
KRINGLE PHARMA, INC. - Original Registrant

Classifications
5 Pharmaceutical, veterinary preparations for liver diseases, renal disease, nerve system diseases, skin diseases, cardiovascular diseases, cancer; Sanitary preparations for medical use; Central nervous system stimulants; Hair growth stimulant; Antipyretic analgesics; Anti-epileptics; Analeptics; Hypnotic sedatives; General anesthetics; Anti-motion sickness preparations; Pharmaceutical preparations acting on the peripheral nervous system; Local anesthetics; Skeletal muscle relaxants; Anhidrotics; Autonomics; Antispasmodics; Diaphoretics; Pharmaceutical preparations acting on the sensory organs; Ophthalmic preparations; Agents for otic and nasal use, namely, nasal spray preparations, eye washes, eye drops, irrigating solutions for eye use; Treatment for eye infection, macular degeneration, retinopathy, rhinitis, and sinusitis; Pharmaceutical antiallergic preparations; Antihistaminics; Cardiovascular treatment preparations; Cardiotonics; Antihypertensives; Vasoconstrictors; Capillary stabilizers; Cerebral hemorrhage prophylactic preparations; Antiarrhythmic preparations; Diuretics; Pharmaceutical preparations acting on respiratory organs; Respiratory stimulants; Anti-cough drops; Antitussive expectorants; Pharmaceutical preparations acting on digestive organs; Gastrointestinal cleaning agents; Clysters; Evacuants (purgatives); Stomachics and digestives; Pharmaceutical preparations for oral use, and for oral inflammation; Emetics; Pharmaceutical preparations for dental purposes for gingivostomatitis, alveolar abscess, and alveoloclasia; Antacids; Antiemetics; Castor oil for medical purposes; Cholagogues; Hormones for medical purposes; Thyroid and para-thyroid hormone preparations; Mixed hormone preparations; Estrogen preparations; Pancreas hormone preparations; Salivary gland hormone preparations; Androgen preparations; Pituitary hormone preparations; Adrenal hormone preparations; Pharmaceutical preparations acting on uro-genital and anal organs; Oxytocics; Anti-hemorrhoidals; Emmenagogues; Contraceptives; Medicated skin care preparations; Pharmaceutical preparations for purulence; Anti-dermoinfectives; Antimicrobials for dermatologic use; Astringents; Anti-inflammatory agents; Analgesics; Anti-itchings; Talcum powder for medical purposes; Medicated baby oils; Medicated baby powders; Medicated bath preparations; Vitamin preparations for medical purposes; Cod-liver oil drops for medical purposes; Mixed vitamin preparations for medical purposes; Vitamin A preparations for medical purposes; Vitamin C preparations for medical purposes; Vitamin D preparations for medical purposes; Vitamin B preparations for medical purposes; Multi-vitamin preparations for medical purposes; Amino acid preparations for medical purposes; Threonine preparations; Tryptophane preparations; Methionine preparations; Lysine preparations; Royal jelly for medical purposes; Calcium supplements for medical purposes; Chondroitin preparations for medical purposes; Protein and amino acid preparations for medical purposes; Saccharide preparations for treating skin diseases, namely, skin ulcer, injury, burn, scleroderma, dematitis, erythroderma, keratosis, dyschromatosis, and lupus erhthematosus; Mineral preparations for medical use; Anticoagulants; Blood substitutes for human and veterinary use; Blood plasma; Hemostatics; Pharmaceutical preparations affecting metabolism; Antidotes; Enzyme preparations for medical purposes; Lactagogues; Lipotropic factor preparations; Pharmaceutical preparations for the treatment of habitual intoxication; Pharmaceutical preparations for activating cellular function; Tumor suppressing agents; Anti-cancer preparations; Anti-sarcoma preparations; Pharmaceutical preparations for treating physically caused lesions; Pharmaceutical preparations for treating heatstroke; Radiation sickness treating drugs; Pharmaceutical preparations for treating chemically caused disorders, namely, chemical burn, side effect of anticancer drugs, and immunosuppresants; Chlorine-detoxication preparations; Arsenic-detoxication preparations; Benzol-detoxication preparations; Antibiotic preparations; Erythromycin preparations; Chloramphenicol preparations; Colistin-polymixin preparations; Sarkomycin preparations; Streptomycin preparations; Thiolutin preparations; Tetracycline preparations; Trichomycin preparations; Mixed antibiotic preparations; Penicillin preparations; Chemotherapeutics; Antisyphilitics; Antituberculous preparations; Sulfonamide preparations; Antileprotic preparations; Biological preparations for medical purposes; Antitoxic sera; Antitoxins; Mixed biological preparations for medical purposes; Preparations for biological tests for medical purposes; Toxoids; Vaccines; Preparations for destroying parasites; Anthelmintics; Odor neutralizing preparations for use on drugs; Pharmaceutical excipients; Diagnostic preparations for medical use; X-ray contrast agents; Diagnostic reagents for medical use; Diagnostic media for bacteriological cultures for medical use; Radio isotope markers for therapeutic or diagnostic use; Opium alkaloid preparations; Synthetic narcotics; Coca alkaloid preparations; Mosquito-repellent incenses; Germicides and fungicides; Rodenticides; Insecticides; Fumigants; Herbicides, namely, weedkillers; Insect-repellents; Antiseptics
42 Testing, inspection or research of pharmaceuticals and genetics; Medical research; Consultancy and providing information services in the field of testing, inspection or research of pharmaceuticals and genetics; Consultancy and providing information services in the field of medical research; Providing medical and scientific research information and advice in the fields of pharmaceuticals and genetics
In the statement, line 2, "2F Saito Bio Incuabator" should be deleted, and 2F Saito Bio Incubator should be inserted.
Color is not claimed as a feature of the mark.
"PHARMA"
KRINGLE PHARMACEUTICAL

Trademark Events
Jun 6, 2020
Notice Of Cancellation Sec. 7 Surrender Emailed
Jun 5, 2020
Cancelled Section 7-Total
Apr 30, 2020
Request For Sect 7 Total Surrender Filed
Jun 4, 2020
Case Assigned To Post Registration Paralegal
Apr 30, 2020
Teas Section 7 Surrender Received
Apr 29, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
Apr 29, 2020
Teas Change Of Correspondence Received
Apr 29, 2020
Teas Change Of Domestic Representatives Address
Apr 29, 2020
Teas Withdrawal Of Attorney Received-Firm Retains
Apr 29, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 29, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 29, 2020
Teas Change Of Owner Address Received
Jun 3, 2019
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Jun 2, 2016
Teas Change Of Correspondence Received
Nov 21, 2014
Correction Under Section 7 ¿ Processed
Nov 21, 2014
Case Assigned To Post Registration Paralegal
Nov 11, 2014
Teas Section 7 Request Received
Nov 11, 2014
Teas Change Of Correspondence Received
Jun 3, 2014
Registered-Supplemental Register
Apr 28, 2014
Law Office Publication Review Completed
Apr 25, 2014
Approved For Registration Supplemental Register
Apr 24, 2014
Teas/Email Correspondence Entered
Apr 24, 2014
Correspondence Received In Law Office
Apr 14, 2014
Assigned To Lie
Apr 1, 2014
Teas Response To Office Action Received
Nov 21, 2013
Notification Of Non-Final Action E-Mailed
Nov 21, 2013
Non-Final Action E-Mailed
Nov 21, 2013
Non-Final Action Written
Nov 19, 2013
Assigned To Examiner
Aug 13, 2013
Notice Of Pseudo Mark E-Mailed
Aug 12, 2013
New Application Office Supplied Data Entered In Tram
Aug 8, 2013
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24